ExchangeDEX+

Buy Crypto Markets Spot FuturesGOLD Earn Event Center

Commodity Zero-Fee Gala

Phathom Pharmaceuticals, Inc. (PHAT)

NASDAQ

$12,01

$-0,22

(-1,84%)

Phathom Pharmaceuticals, Inc. (PHAT) Live Price Chart

Page last updated: 2026-02-12 20:59:44

Key Market Data

Market Cap	$857,75M
Open	$12,38
High	$64,54
Low	$2,21
Previous Close	$12,23
Price Change	$-0,22
Percentage Change	-1,84%
Volume	647K

Phathom Pharmaceuticals, Inc. (PHAT) Stock Price Today

Phathom Pharmaceuticals, Inc. (PHAT) is currently trading at $12,01 as of 2026-02-12 20:59:44, reflecting a -1,84% move ($-0,22) from the previous close.

In the short term, the stock has returned -2 067,37% over the past four weeks. Over the last 12 months, Phathom Pharmaceuticals, Inc. has recorded a +119,16% price change, indicating a strong performance relative to the broader market.

Phathom Pharmaceuticals, Inc. (PHAT) 7-Day Stock Price Changes

Over the past seven days, Phathom Pharmaceuticals, Inc. has traded within a short-term range shaped by market sentiment in the PHARMACEUTICAL PREPARATIONS sector. During this period, the stock moved from its previous closing price of $12,82 to the latest recorded price of $12,01, reflecting an intraday change of -1,84%. Daily movements highlight shifts in trading volume (647 435), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, PHAT has delivered a -2 067,37% return over the past month and a +119,16% change in the last 12 months, indicating a strong trend relative to its broader sector peers.

How to Buy Phathom Pharmaceuticals, Inc. (PHAT)

You can buy and trade PHAT on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for PHAT and Execute Your Trade

Open the trading page, enter PHAT in the search bar, select the amount of PHAT you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is Phathom Pharmaceuticals, Inc. (PHAT)?

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Phathom Pharmaceuticals, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	427
Sector	PHARMACEUTICAL PREPARATIONS
Company Website	https://www.phathompharma.com

Frequently Asked Questions (FAQ)

1.What is the current share price of Phathom Pharmaceuticals, Inc.?

The latest trading price for Phathom Pharmaceuticals, Inc. (Common Stock) is $ 12,01, compared with a previous closing price of $ 12,23. That means the stock has moved -1,84% so far today. Intraday price updates and recent trading activity for PHAT can be tracked on the live chart and quote section on this page.

2.Is Phathom Pharmaceuticals, Inc. stock going up or down?

Looking at recent performances, PHAT has returned -2 067,37% over the past month, +18,91% over the last six months and +119,16% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe strong price momentum for Phathom Pharmaceuticals, Inc. stock, but keep in mind that past returns do not guarantee future results.

3.Where does PHAT currently sit relative to its 52-week high and low?

In the most recent 52-week period, Phathom Pharmaceuticals, Inc. has traded between a low of $ 2,21 and a high of $ 18,31. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether PHAT is currently nearer the top or the bottom of its one-year trading band.

4.How is Phathom Pharmaceuticals, Inc. classified by sector and industry?

Phathom Pharmaceuticals, Inc. is classified in the PHARMACEUTICAL PREPARATIONS sector. In practice, this means Phathom Pharmaceuticals, Inc. is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing PHAT’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the PHARMACEUTICAL PREPARATIONS sector could influence Phathom Pharmaceuticals, Inc.’s performance.

5.Where is Phathom Pharmaceuticals, Inc. listed and how large is it by market value?

Phathom Pharmaceuticals, Inc. is listed on the NASDAQ stock exchange in United States. Based on a market capitalization of $ 857,75M, the company is classified as a Small-cap stock. Market cap gives a quick sense of Phathom Pharmaceuticals, Inc.'s size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does PHAT's EPS tell investors about its profitability?

Trailing-twelve-month EPS of $ -3,52 summarises how much profit Phathom Pharmaceuticals, Inc. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track Phathom Pharmaceuticals, Inc.'s financial performance over time?

To follow Phathom Pharmaceuticals, Inc.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how PHAT is performing and how the market is responding.

8.When is Phathom Pharmaceuticals, Inc. expected to report earnings?

Phathom Pharmaceuticals, Inc.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for PHAT, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in Phathom Pharmaceuticals, Inc.'s earnings reports?

Phathom Pharmaceuticals, Inc.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether PHAT is meeting, beating or missing expectations.

10.How can I stay informed about Phathom Pharmaceuticals, Inc.'s results and guidance?

You can stay up to date on Phathom Pharmaceuticals, Inc. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for PHAT on this page helps you see how new information is being reflected in the stock.

11.Does Phathom Pharmaceuticals, Inc. pay a regular cash dividend to its shareholders?

Phathom Pharmaceuticals, Inc. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of 0 at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor PHAT's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for PHAT?

Based on the latest earnings data, PHAT has a dividend yield of 0 and a dividend payout ratio of 0. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether Phathom Pharmaceuticals, Inc. is an attractive income stock. The dividend payout ratio measures what percentage of earnings Phathom Pharmaceuticals, Inc. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is Phathom Pharmaceuticals, Inc.?

Phathom Pharmaceuticals, Inc. is a publicly traded company in the PHARMACEUTICAL PREPARATIONS industry within the PHARMACEUTICAL PREPARATIONS sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is PHAT valued in terms of P/E ratio and EPS?

Phathom Pharmaceuticals, Inc. currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of $ -3,52. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of Phathom Pharmaceuticals, Inc.'s earnings. Comparing PHAT's P/E and EPS to those of other PHARMACEUTICAL PREPARATIONS companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as Phathom Pharmaceuticals, Inc.

The Walt Disney Company

DIS

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

Coterra Energy Inc.

CTRA

Delta Air Lines, Inc.

DAL

Edison International

EIX

Flutter Entertainment plc

FLUT

JPMorgan Chase & Co.

JPM

Top Gainers

Browse today's leading gainers in the US stock market

Haoxin Holdings Limited

HXHX

IPG Photonics Corporation

IPGP

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

BTC

ETH

SOL

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

PHAT-to-USD Calculator

Amount

PHAT

USD

1 PHAT = 12,01 USD